[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578311":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":20,"locations":26,"responsibleParty":45,"collaborators":11,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":11,"eligibilityCriteria":52,"healthyVolunteers":49,"sex":53,"minAge":54,"maxAge":11,"enrollmentInfo":55,"targetDuration":11,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":11,"overallStatus":64,"whyStopped":11,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"PLU Ophthalmic","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"This is the group that will undergo the surgical treatment","EXPERIMENTAL",null,[13],"Device: Glaucoma surgery",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DEVICE","Glaucoma surgery","This is an implant-free, minimally invasive glaucoma surgery",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},"Carlos A Urrea, MD","CONTACT","215-327-5500","CUrrea@pluophthalmic.com",[27],{"facility":28,"status":11,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"MUSC Storm Eye Institute","Charleston","South Carolina","29424","United States","US",{"type":35,"coordinates":36},"Point",[37,38],-79.93275,32.77632,{"lat":38,"lon":37},[41],{"name":42,"role":23,"phone":43,"phoneExt":11,"email":44},"Jella An, MD","843-792-2020","anjel@musc.edu",{"type":46,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100578311","a-prospective-interventional-cohort-study-to-evaluate-the-efficacy-and-safety-of-the-aqualumen-a-novel-filtration-procedure-for-the-treatment-of-open-angle-glaucoma-100578311",false,"NCT06809647","A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtration Procedure for the Treatment of Open Angle Glaucoma","Inclusion Criteria:\n\n* Moderate to severe open angle glaucoma\n* Central corneal thickness between 480 and 610 microns\n\nExclusion Criteria:\n\n* surgical history of corneal graft\n* presence of corneal opacities\n* Failed prior trabeculectomy","ALL","18 Years",{"count":56,"type":57},10,"ESTIMATED","INTERVENTIONAL",[60],"NA","The study will follow a group of patients with glaucoma disease that undergo a surgical procedure intended to reduce the intra-ocular pressure (IOP) for a period of one year.",[63],"Glaucoma Open-Angle","NOT_YET_RECRUITING","2025-01-30",{"date":67,"type":68},"2025-02-05","ACTUAL",{"date":70,"type":57},"2025-03-30",{"date":72,"type":57},"2026-08-30",{"name":5,"class":6},1]